Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How China's Probe of GlaxoSmithKline Could Play Out
TheStreet.com
Friday, August 2, 2013 - 10:55am
tags:
China, GSK
GlaxoSmithKline diabetes drug faces U.S. approval delay
Reuters
Friday, August 2, 2013 - 10:54am
tags:
GSK, diabetes, albiglutide, FDA
Bayer Lung Drug Should Be Approved at Low Dose, FDA Says
Bloomberg
Friday, August 2, 2013 - 10:53am
tags:
Bayer, FDA, drug approvals, pulmonary hypertension, Riociguat
Endo Health Solutions Earnings Are on Deck
Motley Fool
Friday, August 2, 2013 - 10:52am
tags:
Endo Health Solutions, earnings
Earnings Beat at Mylan
Yahoo/Zacks
Friday, August 2, 2013 - 10:51am
tags:
Mylan, earnings
FDA warns of serious skin rash with acetaminophen pain pills
Reuters
Friday, August 2, 2013 - 10:49am
tags:
FDA, warnings, acetaminophen
Pacira Pharma surgical pain drug Exparel fails in new clinical trial; still plans new filings
Yahoo/AP
Friday, August 2, 2013 - 10:48am
tags:
Pacira, clinical trials, EXPAREL
Teva Pharmaceutical Industries a Top Ranked SAFE Dividend Stock With 3.2% Yield
Forbes
Thursday, August 1, 2013 - 9:49am
tags:
Teva Pharmaceuticals
Ligand Reports Second Quarter Financial Results
Enhanced Online News
Thursday, August 1, 2013 - 9:48am
tags:
Ligand, earnings
Quintiles' $944M in 2Q revenue beats analyst estimates
WRAL TechWire
Thursday, August 1, 2013 - 9:46am
tags:
Quintiles, earnings
Teva Q2 Adj. Profit Matches View, But Revenues Miss - Quick Facts
RTT News
Thursday, August 1, 2013 - 9:37am
tags:
Teva Pharmaceuticals, earnings
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2013 Financial Results
MarketWatch
Thursday, August 1, 2013 - 9:35am
tags:
Keryx, earnings
US FDA Panel backs Sanofi's Nasacort AQ nasal spray
Pharmaceutical Business Review
Thursday, August 1, 2013 - 9:34am
tags:
Sanofi, Nasacort, OTC, allergic rhinitis
Hospira Q2 Adj Profit Tops View, But Revenues Miss; Backs 2013 Outlook
NASDAQ
Thursday, August 1, 2013 - 9:32am
tags:
Hospira, earnings
Cubist Pharma's Buys Look Like Square Deals
Barron's
Thursday, August 1, 2013 - 9:31am
tags:
Cubist, M&A
Lupin Receives Tentative FDA Approvals for Generic Nuvigil Tablets and Generic Oracea Capsules
Sacramento Bee, CA
Thursday, August 1, 2013 - 9:29am
tags:
Lupin, NUVIGIL, Oracea, generics
Are These Diabetes Drugs Safe After All?
Motley Fool
Thursday, August 1, 2013 - 9:17am
tags:
Januvia, Merck, Byetta, Bristol-Myers Squibb, diabetes, type 2 diabetes
Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results
Yahoo/GlobeNewsWire
Thursday, August 1, 2013 - 9:16am
tags:
Astex, earnings
Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks
The Street
Thursday, August 1, 2013 - 9:14am
tags:
Lexicon Pharmaceuticals, LX4211, type 2 diabetes, diabetes
Despite Probes, China's Drug Market To Boom To $315 Billion By 2020
Forbes
Thursday, August 1, 2013 - 9:12am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.